This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Persistent Systems and NVIDIA AI...
Tech AI collaboration

Persistent Systems and NVIDIA AI Drug Discovery

Analysis based on 9 articles · First reported Mar 17, 2026 · Last updated Mar 18, 2026

Sentiment
60
Attention
4
Articles
9
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

This collaboration between Persistent Systems and NVIDIA is expected to positively impact the Healthcare and Life Sciences sector by accelerating drug discovery through advanced AI. It signals a growing trend of technology integration in traditional R&D, potentially leading to increased efficiency and innovation in the market.

Healthcare Life Sciences Technology
Event Summary

Persistent Systems announced a collaboration with NVIDIA to accelerate the development and deployment of AI-powered solutions for the Healthcare and Life Sciences (HLS) industry. This partnership aims to advance computational drug discovery and improve research outcomes using Generative AI and advanced analytics. Persistent Systems will leverage the full-stack NVIDIA AI platform, including NVIDIA AI Enterprise, BioNeMo, NeMo, and Nemotron models, for preclinical research and to build production-grade Agentic AI applications. Specifically, Persistent Systems has created a Generative Molecules and Virtual Screening (GenMoIVS) solution, powered by NVIDIA BioNeMo and NVIDIA NeMo Agent Toolkit, to streamline real-time drug discovery workflows. This initiative is expected to de-risk early-stage discovery, accelerate experimental cycles, and improve success rates in clinical development pipelines for HLS organizations.

Key Actions
95 Persistent Systems collaborated with NVIDIA to accelerate AI solutions for HLS Nvidia
80 Persistent Systems developed Generative Molecules and Virtual Screening (GenMoIVS) solution
70 Persistent Systems expanded AI and LLM engineering capabilities
Entities Involved
stock
Persistent Systems
Persistent Systems is collaborating with NVIDIA to accelerate AI-powered solutions for the Healthcare and Life Sciences industry, specifically in computational drug discovery. This partnership is expected to enhance Persistent Systems' offerings and market position in AI and digital engineering.
Importance 90 Sentiment 70
stock
Nvidia
Nvidia is partnering with Persistent Systems to expand the application of its AI platform, including BioNeMo and NeMo, in the Healthcare and Life Sciences sector. This collaboration further solidifies Nvidia's role as a key enabler of AI-driven innovation across various industries.
Importance 90 Sentiment 70
per
Ganesh Nathella
Ganesh Nathella, Executive Vice President and General Manager - HLS Business at Persistent Systems, commented on the collaboration, highlighting its potential to accelerate drug discovery for biopharma clients.
Importance 30 Sentiment 50
per
John Fanelli
John Fanelli, Vice President - Enterprise Software at NVIDIA, emphasized how the partnership with Persistent Systems empowers biopharma companies with production-grade agentic systems for molecular simulation and virtual screening.
Importance 30 Sentiment 50
Relationships
Persistent Systems related ↔ Nvidia
Ganesh Nathella related ↔ Persistent Systems
John Fanelli related ↔ Nvidia
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.